Excited and honored to present the results from secondary analysis of A011502… need strategies to address pain and stress in breast cancer patients to improve outcomes. Alliance for Clinical Trials in Oncology ASCO Roswell Park #bcsm Oncology Brothers

Honored to have presented our findings on “Polygenic Risk Score & BC Survival Outcomes” at #ASCO24! #breastcancer pts with higher PGS313 had increased risk of recurrence, invasive events & death! Roswell Park Roswell Park Hematology/Oncology Fellowship Christine Ambrosone Kaiser Permanente Research NorCal The ASCO Post OncoAlert Oncology Brothers

Excited to share our new article proposing a dual strategy of chemokine modulation followed by checkpoint inhibitors as an approach to address racial disparity within the TME of #TNBC, especially among Black patients. Jayasree Krishnan Arya Roy Shipra Gandhi ncbi.nlm.nih.gov/pmc/articles/P…

What began last year as a lemonade stand, raising $ for Wilmot, turned into a hotdog stand for this year. they raised $7,500 & Josh Allen in change, surpassing their $600 goal. What a community& a dream.We are so thankful! See ya soon Wilmot Cancer Institute Jonathan Friedberg oh& #gobills

Happy to share our multi-center study on real-world outcomes of Keynote 522. So thankful for the collaboration Lubna Chaudhary MD, MS Saba Shaikh and incredibly grateful for Shipra Gandhi mentorship. Archit Patel Arya Roy Malak Alharbi Ankita Kapoor clinical-breast-cancer.com/article/S1526-…

Approach to bleeding

#Osimertinib now U.S. FDA approved based off #LAURA: Ph III, Indefinite Osimertinib after ChemoXRT in Stage III mEGFR NSCLC: New SoC - ⬆️PFS w/ Osi, 39.1mos vs 5.6mos (HR 0.16) - 2 yr PFS: 65% vs 13% - Improved CNS PFS - ≥Gr 3 AEs: 35% vs 12% #OncTwitter #lcsm #MedTwitter

Excited to share our study on the effectiveness & toxicity of #SG in #mTNBC. T-DXd could be a viable option after SG, for those who had clinical benefit w SG! Thanks to my co-first author Dr. Alaklabi, Shipra Gandhi & co-authors Yara Abdou, MD, MSCR Lubna Chaudhary MD, MS Saba Shaikh

So proud of you!! 👏🏻👏🏻👏🏻

Amazing accomplishment by my star mentee Sawyer Bawek, DO..three years in a row…looking forward to presenting our research at #ASCOGI25 ASCO Roswell Park

What a refreshing start ahead of SABCS! We received invaluable advice from faculty. Key takeaway: our careers and goals evolve as we do—relax and enjoy the ride! Thanks Stephanie Graff, MD, FACP, FASCO Eleonora Teplinsky, MD, FASCO Matteo Lambertini, MD PhD Kevin Kalinsky, MD, MS, FASCO Dr Hurvitz OncLive.com Shipra Gandhi

Thrilled to kick off #SABCS24 on a high note with the Coltman Scholar Award Notification! Grateful for this honor & excited to connect with friends and collaborators! Ohio State Medical Oncology Alexis LeVee, MD Roswell Park SABCS

Important study from Matteo Lambertini, MD PhD & colleagues at #SABCS2024! RRM & prophylactic oophorectomy improved survival outcomes in young #BRCA carriers! Ohio State Medical Oncology OncoDaily Oncology Brothers Hem-Onc Fellows Network

Proud of Azka Ali, MD for representing Cleveland Clinic and SWOG Cancer Research Network during today’s rapid fire oral session at #SABCS2024 with update of S0221 trial. Very interesting outcome differences by race noted and more analyses to come in the upcoming manuscript

#SABCS24 Day 2 Highlights #CommunityOnc: 1. #EMBER3: Oral SERD in HR+ 2. #OlympiA: PARPi in gBRCA 3. #Surgery in gBRCA #bcsm SABCS #OncTwitter #MedTwitter @UTHealthSAMDA AACR

Otto Metzger (Otto Metzger) presents the practice-changing results from the #PATINA phase 3 trial: adding palbociclib to maintenance ET after 1L THP for HR+/HER2+ MBC significantly and meaningfully improved PFS (44 vs 29 months, HR 0.74, p=0.007). 44 months!!!!!!!!!!!!!!!!!!!!!!!!

Excellent discussion by Deepak Vadehra, colorectal specialist on Early stage CRC!! Roswell Park Hematology/Oncology Fellowship Roswell Park